Immediate Impact

1 from Science/Nature 43 standout
Sub-graph 1 of 20

Citing Papers

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
2023 Standout
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
2023 Standout
2 intermediate papers

Works of T Shimamura being referenced

SLCO1B1 Polymorphism Is a Drug Response Predictive Marker for Advanced Pancreatic Cancer Patients Treated With Gemcitabine, S-1, or Gemcitabine Plus S-1
2018
Primary hepatic carcinoid tumor
1996

Author Peers

Author Last Decade Papers Cites
T Shimamura 72 94 12 62 17 168
Andrés Castaño‐García 56 63 12 68 19 151
Han Lin 63 119 7 96 16 271
So-Young Jin 30 41 14 49 14 160
R. Rajagopalan Iyer 29 76 30 98 18 166
Giovanna Sabella 80 60 28 56 22 127
David Kaczmarek 101 78 15 136 17 242
Frederiek Nuytens 74 111 3 159 21 208
S.K.P. John 174 71 21 125 14 273
Kanwarpreet Tandon 68 46 23 58 21 252
Kenichi Koushi 110 77 15 125 15 274

All Works

Loading papers...

Rankless by CCL
2026